Inhibiting EGFR/HER-2 ameliorates neuroinflammatory responses and the early stage of tau pathology through DYRK1A
There are no files associated with this item.
Show Full Item Record
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.